Results 11 to 20 of about 2,657,261 (342)
Customising the therapeutic response of signalling networks to promote antitumor responses by drug combinations [PDF]
Drug resistance, de novo and acquired, pervades cellular signalling networks from one signalling motif to another as a result of cancer progression and/or drug intervention.
Alexey eGoltsov +4 more
doaj +7 more sources
Comparison of null models for combination drug therapy reveals Hand model as biochemically most plausible [PDF]
Mark Sinzger +3 more
openalex +2 more sources
Nanoparticles for combination drug therapy. [PDF]
Ma L, Kohli M, Smith A.
europepmc +2 more sources
Dynamic View on Affordability of Fixed-Dose Combination Antihypertensive Drug Therapy [PDF]
Su Hee Hong, J. Wang, Jiamin Tang
openalex +2 more sources
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
Mycobacterium abscessus is a difficult respiratory pathogen to treat, when compared to other nontuberculus mycobacteria (NTM), due to its drug resistance.
Bui Thi Bich Hanh +7 more
doaj +1 more source
Editorial: Innovative drug combinations for enhanced solid tumor treatment efficacy [PDF]
Giovanna Damia, Massimo Broggini
doaj +2 more sources
Basic principles of combination therapy: focus on drug-drug interaction
The article is devoted to the issue of drug interactions in the combination regimens. Today, when drug therapy is the first-line approach for patients with noncommunicable diseases, and the world population ageing leads to an increase in the number of ...
S. Yu. Martsevich +2 more
doaj +1 more source
Metabolic Derangements with Anticonvulsants in Children with Generalised Tonic-clonic Epilepsy: A Cross-sectional Study [PDF]
Introduction: Epilepsy is one of the most prevalent noncommunicable neurologic conditions, accounting for significant disability and mortality. The effects of Antiepileptic Drugs (AEDs) on total cholesterol, triglycerides, High-Density Lipoprotein ...
Jyoti Sharma +3 more
doaj +1 more source
Background: Drug interactions are important causes of adverse events. Assessments of pharmacological interactions outside healthcare services settings are scarce. Objective: To assess the frequency and factors associated with these potential interactions
Tayanny Margarida Menezes Almeida Biase +2 more
doaj +1 more source
Various nanocarriers have been explored to deliver drugs for combination therapy. However, most nanocarriers are composed of inert materials without contribution for improving the cancer therapeutic effect.
Jingqi Xin +3 more
doaj +1 more source

